Lineage and sublineage analysis of human papillomavirus type 56 in cervical samples of Iranian women

J Med Virol. 2021 Nov;93(11):6412-6417. doi: 10.1002/jmv.27248. Epub 2021 Aug 4.

Abstract

Understanding the regional lineages and sublineages of human papillomavirus type 56 (HPV 56) would be of great importance for further evolutionary, epidemiological, and biological investigations. To identify the distribution of lineages and sublineages of HPV 56 in Iran, the sequence variations of the E6 gene were analyzed in normal, premalignant, and malignant samples obtained from the cervix. In total, 58 HPV 56-positive samples were investigated by nested-PCR and followed by bidirectional direct nucleotide sequencing analysis. Both lineages A and B were identified in the studied samples. Lineage B was dominant as it was detected in 88.4% of all samples and the remaining samples belonged to lineage A (11.6%). Sublineages A1 and A2 were detected in 3.3% and 8.3% of all samples, respectively. With regard to the pathological stages of cervical specimens, no statistically significant differences were found in the three studied groups (p > 0.05). In conclusion, our findings showed that lineage B of HPV 56 was prevalent in Iran. However, further studies with a larger sample size are warranted to estimate the pathogenicity risk of HPV 56 lineages/sublineages to the progression of cervical cancer among Iranian women.

Keywords: cervical cancer; genotype; human papillomavirus; lineage; sublineage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cervix Uteri / virology*
  • Cross-Sectional Studies
  • DNA, Viral / genetics
  • Female
  • Genetic Variation*
  • Genotype
  • Humans
  • Iran
  • Middle Aged
  • Oncogene Proteins, Viral / genetics
  • Papillomaviridae / classification*
  • Papillomaviridae / genetics*
  • Papillomaviridae / isolation & purification
  • Papillomaviridae / pathogenicity
  • Papillomavirus Infections / virology*
  • Uterine Cervical Dysplasia / virology*
  • Uterine Cervical Neoplasms / classification
  • Uterine Cervical Neoplasms / pathology
  • Uterine Cervical Neoplasms / prevention & control
  • Uterine Cervical Neoplasms / virology*

Substances

  • DNA, Viral
  • Oncogene Proteins, Viral